Skip to main content

Advertisement

Brain Radiation Information Data Exchange (BRIDE): integration of experimental data from low-dose ionising radiation research for pathway discovery

Abstract

Background

The underlying molecular processes representing stress responses to low-dose ionising radiation (LDIR) in mammals are just beginning to be understood. In particular, LDIR effects on the brain and their possible association with neurodegenerative disease are currently being explored using omics technologies.

Results

We describe a light-weight approach for the storage, analysis and distribution of relevant LDIR omics datasets. The data integration platform, called BRIDE, contains information from the literature as well as experimental information from transcriptomics and proteomics studies. It deploys a hybrid, distributed solution using both local storage and cloud technology.

Conclusions

BRIDE can act as a knowledge broker for LDIR researchers, to facilitate molecular research on the systems biology of LDIR response in mammals. Its flexible design can capture a range of experimental information for genomics, epigenomics, transcriptomics, and proteomics. The data collection is available at: <bride.azurewebsites.net>.

Background

In recent years, industrial societies have experienced a significant increase of exposure to low-dose ionising radiation (LDIR), with possible implications for human health and disease [1]. The known causes of LDIR exposure typically arise from advanced medical diagnostic procedures [2], air travel [3] and nuclear industry incidents, including the major Chernobyl [4] and Fukushima [5] disasters. Other effects might involve specific population groups, for instance health professionals with frequent exposure to ionising radiation or space travelers [6]. Examples of acute doses that motivate much of LDIR research include medical diagnostic procedures or radiotherapy treatment. It is estimated that, in total, the annual increase to LDIR exposure has dramatically risen on average from 0.5 mSv in 1980 to 3 mSv today, particularly in the industrial world [7]. This general trend stipulates the intensification of research on LDIR effects on health – both chronic and acute [8], in particular the understanding of molecular mechanisms involved with a view to radiation protection as well as the mitigation of those effects by policies or precautionary measures at low- or even moderate-ionising radiation doses [9].

Since the early days of LDIR research, questions regarding health effects at the molecular and system levels have been raised [1012]. Early studies with variable doses concentrated on certain tissues, e.g. skin [13] or bone [14] and molecules, e.g. thioredoxins [15]. Subsequently, comparisons between normal and neoplastic cell lines [16] and studies of cellular processes such as apoptosis [17] have contributed towards a deeper appreciation of the complex responses to LDIR, with implications for human health [18] or specific situations, e.g. air [3] or space [19] travel.

Despite significant progress, it was not until a decade ago that a better understanding has emerged with regard to the underlying molecular processes involved in the LDIR response [20]. The most pertinent studies have highlighted those effects with low dose for skin [21] and higher doses for the cardiovascular system [22, 23] – first recorded in tissue culture and later as models for human physiology at the whole-tissue level. The genome-wide quest for reliable biomarker molecules for radiation exposure has been instigated recently [24, 25], with focus on individual molecules [26, 27], proteomics at high [28, 29] or low [30, 31] doses, and expression studies [3234] or particular conditions, for example effects on neurodegenerative disease [35, 36]. To our knowledge, the lowest doses ever published for radiation effects involve 20 mGy for mouse heart [37] and liver [38].

While LDIR effects for skin or heart have been extensively recognized, very little is currently known for their action in the cerebrovascular system and the brain [9, 39]. To access this black box of human physiology, integrated approaches with mouse models and molecular, cellular, organismal, behavioral, and epidemiological components are becoming vital [40]. These complex data landscapes need to be organized and analyzed using proper data integration platforms – by merging relevant databases, experimental resources, analytical tools and systems biology [41].

Construction and content

Data integration requirements

In our efforts to record and analyze relevant experimental and computational information for LDIR effects on the brain, we have taken a light-weight approach to data integration [42]. Previously, several approaches have attempted to address critical bottlenecks in the integration of complex biological data, such as disregard of commonly accepted data standards, variable user interfaces, lack of collaborative spaces, immature data exchange services and time consuming pipelines for advanced bioinformatics analysis [43]. The continuing increase of data volumes creates additional obstacles in both processing and analysis. The concept of big data combined with cloud services [44] provides a direction for new solutions to the above mentioned challenges.

There are several ways of achieving integration between data resources, including biological databases and lab data collections. First, the data warehouse concept proposes the creation of a local data repository to facilitate queries executed locally; second, the single-database engine approach offers more efficient access via queries, which however need to be executed locally using full indexing; third, hypertext link integration provides opportunities for less structured collections, with the predictable drawback of complex data navigation [45]. The rise of web technologies contributes towards the development of new protocols and platforms called Web Services that maintain a middle ground between the above options, in order to exchange data between different data resources or systems. Typical examples of such approaches are based on Service-Oriented Architectures (SOAs) [46] or REpresentational State Transfer (REST) [47].

In our work, the integration of data resources in the context of LDIR research presented two challenges: first, to assemble relevant publicly available omics data – including transcriptomics and proteomics for a number of conditions, tissues and phenotypes under consideration, and second, to include novel experimental data from collaborating laboratories within a framework that will lead to molecular systems biology-based pathway inference and biomarker discovery. Thus, the high-level requirements for data integration in LDIR research in non-technical language are: the recording of the identity of relevant molecules (i.e. with sequence identifiers), the quality control of the imported data from the literature and own experiments, and the secure transfer and access of those data by partner laboratories and researchers, as well as a public access portal.

In line with the primary aims and the four high-level requirements mentioned above, we have developed a platform for LDIR research called BRIDE. BRIDE provides access to a number of tasks displayed as tabs for users, including editing gene lists and tools, while implementing light-weight integration with a number of hand-picked, relevant web services for computational systems biology, including genomics, transcriptomics, proteomics and phenotype data resources [41].

We have thus combined results recorded from an exhaustive analysis of the existing literature with our own experimental results. We have created ‘unification links’ connecting molecules with their corresponding database entries and ‘relationship links’ connecting molecules with their biological context [48], associating them with co-expressed genes, protein interactions or cellular pathways [49]. BRIDE supports access via a web browser client [50]. This type of integration is called navigational or link-based, and can be ideal for development efforts with modest resources [45].

System architecture

The BRIDE platform implementation is based on the Microsoft® (MS®) computational ecosystem. According to our extensive research at the early development phase, there are several examples with successful implementations of bioinformatics projects using MS® solutions [51]. Thus, we have decided to implement a scalable, robust, industry-strength solution for BRIDE. The development was attained with Visual Studio 2012 [52], using in particular the LightSwitch tool. From the architectural point of view, the BRIDE platform is a browser client, 3-tier system [53]. This deployment scenario creates an application that runs via the end-user’s web browser. The database and server components run on a database server, running on web MS® IIS server.

The LightSwitch component executes widely-used MS® technologies and patterns like Entity Framework for data access, n-tier application layers and Model-View-View-Model (MVVM) [54]. This type of architecture allows for any system component to be modified without having to change the other two parts of the 3-tier architecture, therefore facilitating maintenance and response to changes. The tiers of the platform communicate through interfaces. Therefore, as long as the interface remains stable, the internals can change without affecting the rest of the platform.

With 3-tier applications, the business rulesFootnote 1 and queries are removed from the client and are executed on a system between the user interface (e.g. client browser) and the data storage system (in this case, the MS® SQL database). The client application provides a standard user interface or a presentation layer for the platform. The business rules server ensures that all of the business processing and queries is executed properly, and serves as an intermediary between the client and the data storage layers. Note that, in this type of application, the client does not access the data storage system directly. The final deployment is based on a MS® platform: local servers run the Windows® 2008 R2 Server operating system, FTP server, MS® SQL 2012 Server relational database management system and MS® Azure cloud services and can be replicated at other sites (Fig. 1). According to our usage pattern, planning the hybrid cloud solution fits optimally to our needs: this solution ensures data security, with the database hosted locally, while the presentation layer or the web site is hosted on the cloud. The main benefits for the cloud-based services are lower costs, a significant decrease in development time and low system administration workloads.

Fig. 1
figure1

BRIDE system architecture. The 3-tier architecture between storage, processing and presentation

The steps in the data preparation process were as follows: (i) partner laboratories submitted their experimental results to the BRIDE storage site via a secure FTP server – accepted formats are MS® Excel files or tab-delimited text files. The recommended fields were: gene name (used from the corresponding reference genome), organism (mouse in this case), tissue (brain or other tissues), time after irradiation, radiation dose (metadata) and lab (identification); (ii) using Google Refine [55], an open source power tool for cleaning large data sets, we were able to convey and store data, using http requests and stripping techniques, and (iii) subsequently enrich the submitted collections with identification names from different resources – e.g. UniProt protein identifiers [56] based on gene names; (iv) the final table is exported to MS® SQL production database; (v) finally, we have generated all ‘unification’ links using SQL store procedures. The data preparation stage offered a seamless pipeline to prepare the data for submission. Using SQL store procedures, it is easy to update links in case a data provider issues any alterations to their web-services definitions.

Data consumption

End users are thus able to access all BRIDE data at two different levels: (i) Users can access a fully searchable gene catalog via their browser, through unification or relationship links. ‘Unification links’ connect gene entries with their corresponding database records [48]. We have also managed to integrate data contents from NCBI resources [57], the IntAct protein interaction database [58], the Allen Brain Atlas [59] and Rb-STORE (www.rbstore.eu/) into BRIDE, with a view to continue capturing information from molecular resources against a rich backdrop of phenotypic features relevant to systems radiobiology, as needs arise (Fig. 2). The links within BRIDE, and across data resources, were built using the available REST APIs, which are distinct for each data repository. The corresponding actions (input/output) for unification links are listed in Table 1. ‘Relationship links’ connect molecules with their local biological context, as mentioned above [48]. Users may select more than one molecule and search for their respective pathways using the PCViz component of the PathwayCommons resource [60], accessible at <pathwaycommons.org/pcviz/>.

Fig. 2
figure2

BRIDE gene catalog. A detailed screenshot of BRIDE’s gene catalog, with entities described

Table 1 BRIDE integration with data resources

(ii) The second method available for BRIDE data consumption is based on the MS® Open Data (OData) technical protocol [61]. OData defines an abstract data model allowing different clients to access those data programmatically. OData builds on AtomPub, an abstract implementation of a REST design pattern, ignoring some of the REST constraints in the process. OData services require URIs construction to enable the protocol querying capability and returns results in XML (Fig. 3) or JSON formats [62]. The benefit of this protocol implementation is that users can access data in a high-throughput mode or use tools like the MS® Excel plugin Pivot, in order to import data and proceed to further analysis locally – e.g. by including those data into the popular Ingenuity® suite.

Fig. 3
figure3

OData XML results. Example results in XML format

To achieve the above goals following the specified user requirements, in particular to provide a systems biology context for the LDIR response at the molecular level, one needs to first identify the molecules under consideration and second to understand their interactions with other molecules at different levels of expression. Coupled with the experimental efforts within the CEREBRAD project for transcriptomics and proteomics, we plan to explore this landscape of relevant molecules and interactions to better understand LDIR response in the brain (manuscript in preparation).

Data contents

Currently, the BRIDE collection contains 3,174 relevant records defined uniquely by the tuple: ‘tissue-dose-time (after irradiation)’. The majority of these entries (3,016, or 95 %) correspond to protein-coding genes detected in the mouse brain, according to the original studies (recorded as PubMed identifiers – PMIDs) – this does not necessarily mean that they are brain-specific. A small minority of proteins are found in other tissues as well, and have been included due to their mentions in the same experimental recordings. These entries might further be used as controls in brain studies – for instance, inclusion of those entries in future brain-related studies. Most records are compiled from four publications associated with the CEREBRAD project, referred again by their PMID numbers, 3009 in total (or 95 %): more precisely, 533 [35], 182 [63], 1828 [64], 312 [65] and another 154 unpublished instances. The remaining 165 instances have been recorded manually by scanning over hundreds of relevant articles in the literature, and selecting six additional publicatoins – their PMIDs are also provided [28, 29, 49, 6669]. For all these gene entries, unification and relationship links were generated, where possible. Averaging ~18 links per molecule (Table 1), we have >55,000 links at our disposal. Thus, the corpus of data within BRIDE is extremely rich as well as challenging to explore, for pathway inference in the context of radiation effects on the brain, e.g. cognitive deficits in adult, prenatally exposed mice [70, 71]. These links also provide critical histology and other experimental evidence for the involvement of the corresponding genes in brain function, e.g. the Allen Mouse Brain Atlas.

The other two elements defining uniqueness of the recorded entries in the BRIDE data collection, namely dosimetry and time, are less uniform thus reflecting a wide range of experimental designs or conditions (Table 2): for instance, 48 % of records refer to doses <1 Gy while 46 % of records have been observed at more than 5 weeks since irradiation. A small number (133 in total) of entries were not assigned to a specific dosimetry-time as these observations came from the scanner literature, with unclear experimental details (but are recorded for completess and can be filtered out).

Table 2 Dose and Time statistics for all records in the BRIDE data collection

Utility and discussion

The BRIDE platform is an easy-to-use resource with a clean design, modest development efforts, and wider applicability in radiobiology research that supports our joint efforts and distributes the obtained results to the wider community. We have primarily taken a gene/protein-oriented approach with the view that a genome browser-like design would be both labor-intensive and of unclear relevance at this exploratory phase of LDIR response. Database development and implementation have been based on modern software technologies and protocols. The fundamental design principles were platform usability and portal access, which expand data consumption options available to end users. We have thus minimized the effort of platform management by utilizing a hybrid cloud deployment method. The automated data preparation pipeline currently allows scientists to focus on their studies and not wrangle with data formats. Finally, Uniform resource identifier (URI) integration links are easily updated in case of web service modifications by data providers. Further integration with other parallel efforts, such as Radiation Genes [72] or NIF [73], might be possible in the future.

Conclusion

The BRIDE platform can act as a knowledge broker for LDIR researchers, to cope with the ever-increasing amounts of data, their heterogeneous nature, the varying landscape of data types and formats, and the expanding resources for genomics, epigenomics, transcriptomics, and proteomics in LDIR research – as well as a community data portal. As the project evolves, we will understand better the requirements and improve the peer-to-peer communication of scientific results between stakeholders, with the aspiration that BRIDE is used widely by the LDIR community and beyond [74]. While we are still in the process of analyzing these results and other omics aspects of LDIR response (manuscript in preparation), the BRIDE data integration platform design already allows direct use and design modifications that can capture additional types of information from next-generation sequencing (NGS), as well as epigenomics and behavioral data.

Availability and requirements

The BRIDE platform can be accessed with a web browser at <bride.azurewebsites.net>.

Consent

No ethics approval was required for this work, as all results reported have already been published elsewhere.

Notes

  1. 1.

    This is a technical term, does not correspond to the colloquial use of the word.

Abbreviations

mGy:

1/1000 Gray

mSv:

1/1000 Sievert

References

  1. 1.

    Mullenders L, Atkinson M, Paretzke H, Sabatier L, Bouffler S. Assessing cancer risks of low-dose radiation. Nat Rev Cancer. 2009;9(8):596–604.

  2. 2.

    Einstein AJ. Medical imaging: the radiation issue. Nat Rev Cardiol. 2009;6(6):436–8.

  3. 3.

    De Angelis G, Caldora M, Santaquilani M, Scipione R, Verdecchia A. Radiation exposure of civilian airline crew members and associated biological effects due to the atmospheric ionizing radiation environment. Phys Med. 2001;17 Suppl 1:258–60.

  4. 4.

    Ginzburg HM, Reis E. Consequences of the Nuclear Power Plant Accident at Chernobyl. In: US Department of Energy; 1987. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1580196/pdf/pubhealthrep1500192-1580034.pdf.

  5. 5.

    Butler D. Radioactivity spreads in Japan. Nature. 2011;471(7340):555–6.

  6. 6.

    Bonner WM. Low-dose radiation: thresholds, bystander effects, and adaptive responses. Proc Natl Acad Sci U S A. 2003;100(9):4973–5.

  7. 7.

    Thompson G. Unmasking the truth: the science and policy of low-dose ionizing radiation. Bull At Sci. 2012;68(3):44–50.

  8. 8.

    Chaudhry MA, Omaruddin RA, Kreger B, de Toledo SM, Azzam EI. Micro RNA responses to chronic or acute exposures to low dose ionizing radiation. Mol Biol Rep. 2012;39(7):7549–58.

  9. 9.

    Kempf SJ, Azimzadeh O, Atkinson MJ, Tapio S. Long-term effects of ionising radiation on the brain: cause for concern? Radiat Environ Biophys. 2013;52(1):5–16.

  10. 10.

    Weichselbaum RR, Hallahan DE, Sukhatme V, Dritschilo A, Sherman ML, Kufe DW. Biological consequences of gene regulation after ionizing radiation exposure. J Natl Cancer Inst. 1991;83(7):480–4.

  11. 11.

    Nussbaum RH, Kohnlein W. Inconsistencies and open questions regarding low-dose health effects of ionizing radiation. Environ Health Perspect. 1994;102(8):656–67.

  12. 12.

    Holbrook NJ, Liu Y, Fornace Jr AJ. Signaling events controlling the molecular response to genotoxic stress. EXS. 1996;77:273–88.

  13. 13.

    Kim JH, Hahm KH, Cho CK, Yoo SY. Protein biosynthesis in low dose ionizing radiation-adapted human melanoma cells. J Radiat Res. 1996;37(3):161–9.

  14. 14.

    Dare A, Hachisu R, Yamaguchi A, Yokose S, Yoshiki S, Okano T. Effects of ionizing radiation on proliferation and differentiation of osteoblast-like cells. J Dent Res. 1997;76(2):658–64.

  15. 15.

    Hoshi Y, Tanooka H, Miyazaki K, Wakasugi H. Induction of thioredoxin in human lymphocytes with low-dose ionizing radiation. Biochim Biophys Acta. 1997;1359(1):65–70.

  16. 16.

    Park SH, Lee Y, Jeong K, Yoo SY, Cho CK, Lee YS. Different induction of adaptive response to ionizing radiation in normal and neoplastic cells. Cell Biol Toxicol. 1999;15(2):111–9.

  17. 17.

    Shankar B, Premachandran S, Bharambe SD, Sundaresan P, Sainis KB. Modification of immune response by low dose ionizing radiation: role of apoptosis. Immunol Lett. 1999;68(2–3):237–45.

  18. 18.

    Prasad KN, Cole WC, Hasse GM. Health risks of low dose ionizing radiation in humans: a review. Exp Biol Med (Maywood). 2004;229(5):378–82.

  19. 19.

    Cucinotta FA, Schimmerling W, Wilson JW, Peterson LE, Badhwar GD, Saganti PB, Dicello JF. Space radiation cancer risks and uncertainties for Mars missions. Radiat Res. 2001;156(5 Pt 2):682–8.

  20. 20.

    Feinendegen LE, Pollycove M, Sondhaus CA. Responses to low doses of ionizing radiation in biological systems. Nonlinearity Biol Toxicol Med. 2004;2(3):143–71.

  21. 21.

    Goldberg Z, Schwietert CW, Lehnert B, Stern R, Nami I. Effects of low-dose ionizing radiation on gene expression in human skin biopsies. Int J Radiat Oncol Biol Phys. 2004;58(2):567–74.

  22. 22.

    Jadhav U, Mohanam S. Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells. Int J Oncol. 2006;29(6):1525–31.

  23. 23.

    Azimzadeh O, Scherthan H, Sarioglu H, Barjaktarovic Z, Conrad M, Vogt A, Calzada-Wack J, Neff F, Aubele M, Buske C,et al. Rapid proteomic remodeling of cardiac tissue caused by total body ionizing radiation. Proteomics. 2011;11(16):3299–311.

  24. 24.

    Marchetti F, Coleman MA, Jones IM, Wyrobek AJ. Candidate protein biodosimeters of human exposure to ionizing radiation. Int J Radiat Biol. 2006;82(9):605–39.

  25. 25.

    Pernot E, Hall J, Baatout S, Benotmane MA, Blanchardon E, Bouffler S, El Saghire H, Gomolka M, Guertler A, Harms-Ringdahl M et al. Ionizing radiation biomarkers for potential use in epidemiological studies. Mutat Res. 2012;751(2):258–86.

  26. 26.

    Fan M, Ahmed KM, Coleman MC, Spitz DR, Li JJ. Nuclear factor-kappaB and manganese superoxide dismutase mediate adaptive radioresistance in low-dose irradiated mouse skin epithelial cells. Cancer Res. 2007;67(7):3220–8.

  27. 27.

    Ahmed KM, Fan M, Nantajit D, Cao N, Li JJ. Cyclin D1 in low-dose radiation-induced adaptive resistance. Oncogene. 2008;27(53):6738–48.

  28. 28.

    Guipaud O, Holler V, Buard V, Tarlet G, Royer N, Vinh J, Benderitter M. Time-course analysis of mouse serum proteome changes following exposure of the skin to ionizing radiation. Proteomics. 2007;7(21):3992–4002.

  29. 29.

    Lee YS, Chang HW, Jeong JE, Lee SW, Kim SY. Proteomic analysis of two head and neck cancer cell lines presenting different radiation sensitivity. Acta Otolaryngol. 2008;128(1):86–92.

  30. 30.

    Pluder F, Barjaktarovic Z, Azimzadeh O, Mortl S, Kramer A, Steininger S, Sarioglu H, Leszczynski D, Nylund R, Hakanen A et al. Low-dose irradiation causes rapid alterations to the proteome of the human endothelial cell line EA.hy926. Radiat Environ Biophys. 2011;50(1):155–66.

  31. 31.

    Barjaktarovic Z, Anastasov N, Azimzadeh O, Sriharshan A, Sarioglu H, Ueffing M, Tammio H, Hakanen A, Leszczynski D, Atkinson MJ et al. Integrative proteomic and microRNA analysis of primary human coronary artery endothelial cells exposed to low-dose gamma radiation. Radiat Environ Biophys. 2013;52(1):87–98.

  32. 32.

    Guerquin MJ, Duquenne C, Coffigny H, Rouiller-Fabre V, Lambrot R, Bakalska M, Frydman R, Habert R, Livera G. Sex-specific differences in fetal germ cell apoptosis induced by ionizing radiation. Hum Reprod. 2009;24(3):670–8.

  33. 33.

    Verheyde J, Benotmane MA. Unraveling the fundamental molecular mechanisms of morphological and cognitive defects in the irradiated brain. Brain Res Rev. 2007;53(2):312–20.

  34. 34.

    Amundson SA, Bittner M, Meltzer P, Trent J, Fornace Jr AJ. Induction of gene expression as a monitor of exposure to ionizing radiation. Radiat Res. 2001;156(5 Pt 2):657–61.

  35. 35.

    Kempf SJ, Buratovic S, von Toerne C, Moertl S, Stenerlow B, Hauck SM, Atkinson MJ, Eriksson P, Tapio S. Ionising radiation immediately impairs synaptic plasticity-associated cytoskeletal signalling pathways in HT22 cells and in mouse brain: an In Vitro/In Vivo comparison study. PLoS One. 2014;9(10):e110464.

  36. 36.

    Kempf SJ, Casciati A, Buratovic S, Janik D, von Toerne C, Ueffing M, Neff F, Moertl S, Stenerlow B, Saran A et al. The cognitive defects of neonatally irradiated mice are accompanied by changed synaptic plasticity, adult neurogenesis and neuroinflammation. Mol Neurodegener. 2014;9:57.

  37. 37.

    Bakshi MV, Barjaktarovic Z, Azimzadeh O, Kempf SJ, Merl J, Hauck SM, Eriksson P, Buratovic S, Atkinson MJ, Tapio S. Long-term effects of acute low-dose ionizing radiation on the neonatal mouse heart: a proteomic study. Radiat Environ Biophys. 2013;52(4):451–61.

  38. 38.

    Bakshi MV, Azimzadeh O, Barjaktarovic Z, Kempf SJ, Merl-Pham J, Hauck SM, Buratovic S, Eriksson P, Atkinson MJ, Tapio S. Total body exposure to low-dose ionizing radiation induces long-term alterations to the liver proteome of neonatally exposed mice. J Proteome Res. 2015;14(1):366–73.

  39. 39.

    Loganovsky K. Do low doses of ionizing radiation affect the human brain? Data Sci J. 2009;8:BR13–35.

  40. 40.

    UNSCEAR. Biological Mechanisms of Radiation Actions at the Low Doses. In: UNSCEAR; 2012. http://www.unscear.org/docs/reports/Biological_mechanisms_WP_12-57831.pdf.

  41. 41.

    Durrant C, Swertz MA, Alberts R, Arends D, Moller S, Mott R, Prins P, van der Velde KJ, Jansen RC, Schughart K. Bioinformatics tools and database resources for systems genetics analysis in mice--a short review and an evaluation of future needs. Brief Bioinform. 2012;13(2):135–42.

  42. 42.

    Philippi S, Kohler J. Addressing the problems with life-science databases for traditional uses and systems biology. Nat Rev Genet. 2006;7(6):482–8.

  43. 43.

    Fuller JC, Khoueiry P, Dinkel H, Forslund K, Stamatakis A, Barry J, Budd A, Soldatos TG, Linssen K, Rajput AM. Biggest challenges in bioinformatics. EMBO Rep. 2013;14(4):302–4.

  44. 44.

    Marx V. Biology: the big challenges of big data. Nature. 2013;498(7453):255–60.

  45. 45.

    Hernandez T, Kambhampati S. Integration of biological sources: current systems and challenges ahead. SIGMOD Rec. 2004;33:51–60.

  46. 46.

    Korotkiy M, Top J. OntoSOA: From Ontology-enabled SOA to Service-enabled Ontologies. In: Proceedings of the Advanced International Conference on Telecommunications and International Conference on Internet and Web Applications and Services (AICT/ICIW 2006). 2006.

  47. 47.

    zur Muehlen M, Nickerson JV, Swenson KD. Developing web services choreography standards—the case of REST vs. SOAP. Decis Support Syst. 2005;40(1):9–29.

  48. 48.

    Karp PD. Database links are a foundation for interoperability. Trends Biotechnol. 1996;14(8):273–9.

  49. 49.

    Lin RX, Zhao HB, Li CR, Sun YN, Qian XH, Wang SQ. Proteomic analysis of ionizing radiation-induced proteins at the subcellular level. J Proteome Res. 2009;8(1):390–9.

  50. 50.

    Philippi S. Light-weight integration of molecular biological databases. Bioinformatics. 2003;20(1):51–7.

  51. 51.

    Borozan I, Wilson S, Blanchette P, Laflamme P, Watt SN, Krzyzanowski PM, Sircoulomb F, Rottapel R, Branton PE, Ferretti V. CaPSID: a bioinformatics platform for computational pathogen sequence identification in human genomes and transcriptomes. BMC Bioinformatics. 2012;13:206.

  52. 52.

    Microsoft Corp. Visual Studio. http://www.visualstudio.com edn; 2012.

  53. 53.

    Microsoft Corp. Three-tier Application Model. In: Microsoft Corp. 1998. http://msdn.microsoft.com/en-us/library/.

  54. 54.

    Patel J, Okamoto S, Dascalu SM, Harris FC. Web-Enabled Toolkit for Data Interoperability Support. In: Proceedings of the 2012 ISCA International Conference on Software Engineering and Data Engineering. Los Angeles CA; 2012; 161–166.

  55. 55.

    Google Inc. Google Refine. openrefine.org; 2013.

  56. 56.

    UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 2015;43(Database issue):D204–212.

  57. 57.

    NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2014;42(D1):D7–D17.

  58. 58.

    Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F, Chen C, Duesbury M, Dumousseau M, Feuermann M, Hinz U et al. The IntAct molecular interaction database in 2012. Nucleic Acids Res. 2012;40(Database issue):D841–846.

  59. 59.

    Jones AR, Overly CC, Sunkin SM. The Allen Brain Atlas: 5 years and beyond. Nat Rev Neurosci. 2009;10(11):821–8.

  60. 60.

    Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, Anwar N, Schultz N, Bader GD, Sander C. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 2011;39(Database issue):D685–690.

  61. 61.

    Microsoft Corp.: Open Data Protocol. http://www.odata.org/; 2012.

  62. 62.

    Chappell D. Introducing OData: Data Access for the Web, the cloud, mobile devices, and more. In: Microsoft Corp. 2012. p. 1–23.

  63. 63.

    Kempf SJ, Moertl S, Sepe S, von Toerne C, Hauck SM, Atkinson MJ, Mastroberardino PG, Tapio S. Low-dose ionizing radiation rapidly affects mitochondrial and synaptic signaling pathways in murine hippocampus and cortex. J Proteome Res. 2015;14(5):2055–64.

  64. 64.

    Kempf SJ, Sepe S, von Toerne C, Janik D, Neff F, Hauck SM, Atkinson MJ, Mastroberardino PG, Tapio S. Neonatal irradiation leads to persistent proteome alterations involved in synaptic plasticity in the mouse hippocampus and cortex. J Proteome Res. 2015;14(11):4674–86.

  65. 65.

    Kempf SJ, von Toerne C, Hauck SM, Atkinson MJ, Benotmane MA, Tapio S. Long-term consequences of in utero irradiated mice indicate proteomic changes in synaptic plasticity related signalling. Proteome Sci. 2015;13:26.

  66. 66.

    Rithidech KN, Honikel L, Rieger R, Xie W, Fischer T, Simon SR. Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to (137)Cs gamma rays. Int J Radiat Biol. 2009;85(5):432–47.

  67. 67.

    Zuo YH, Wang XL, Li JG, Dang XH, Wang ZW, Zhang SP, Tong J. Proteomic alterations in progeny of irradiated human liver cells. J Toxicol Environ Health A. 2010;73(7):520–8.

  68. 68.

    Lim YB, Pyun BJ, Lee HJ, Jeon SR, Jin YB, Lee YS. Proteomic identification of radiation response markers in mouse intestine and brain. Proteomics. 2011;11(7):1254–63.

  69. 69.

    Ummanni R, Mundt F, Pospisil H, Venz S, Scharf C, Barett C, Falth M, Kollermann J, Walther R, Schlomm T et al. Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform. PLoS One. 2011;6(2):e16833.

  70. 70.

    Quintens R, Verreet T, Janssen A, Neefs M, Leysen L, Michaux A, Verslegers M, Samari N, Pani G, Verheyde J et al. Identification of novel radiation-induced p53-dependent transcripts extensively regulated during mouse brain development. Biol Open. 2015;4(3):331–44.

  71. 71.

    Verreet T, Quintens R, Van Dam D, Verslegers M, Tanori M, Casciati A, Neefs M, Leysen L, Michaux A, Janssen A et al. A multidisciplinary approach unravels early and persistent effects of X-ray exposure at the onset of prenatal neurogenesis. J Neurodev Disord. 2015;7(1):3.

  72. 72.

    Chiani F, Iannone C, Negri R, Paoletti D, D’Antonio M, De Meo PD, Castrignano T. Radiation Genes: a database devoted to microarrays screenings revealing transcriptome alterations induced by ionizing radiation in mammalian cells. Database. 2009;2009:bap007.

  73. 73.

    Cachat J, Bandrowski A, Grethe JS, Gupta A, Astakhov V, Imam F, Larson SD, Martone ME. A survey of the neuroscience resource landscape: perspectives from the neuroscience information framework. Int Rev Neurobiol. 2012;103:39–68.

  74. 74.

    McAllister KA, Lorimore SA, Wright EG, Coates PJ. In vivo interactions between ionizing radiation, inflammation and chemical carcinogens identified by increased DNA damage responses. Radiat Res. 2012;177(5):584–93.

Download references

Acknowledgements

The development of BRIDE has been wholly supported by the collaborative European project CEREBRAD (grant agreement # 295552), within the 7th EU framework programme, Nuclear Fission and Radiation Protection. We thank all CEREBRAD partners for their contributions.

Author information

Correspondence to Soile Tapio or Mohammed Abderrafi Benotmane or Christos A. Ouzounis.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

CK, SJK, RQ and CAO designed, implemented and tested the database system. SJK, RQ, OA, VLV, SP, DB, PGM have contributed datasets and provided experimental information and feedback. ST, MAB, ST, ZGS and CAO have coordinated data exchange and supervised the effort. All authors read and approved the final manuscript.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Karapiperis, C., Kempf, S.J., Quintens, R. et al. Brain Radiation Information Data Exchange (BRIDE): integration of experimental data from low-dose ionising radiation research for pathway discovery. BMC Bioinformatics 17, 212 (2016). https://doi.org/10.1186/s12859-016-1068-8

Download citation

Keywords

  • Low-dose ionising radiation
  • Data integration
  • Brain research
  • Omics technologies
  • Systems biology